Advertisement
Product › Details
CancerNav technology
Next higher product group | biomarker discovery technology_o | |
Status | 2012-01-18 development existent | |
Organisation | Oxford Cancer Biomarkers Ltd. | |
Group | Iqvia (Group) | |
Original research | University of Oxford | |
Record changed: 2023-07-10 |
Advertisement
More documents for biomarker discovery technology_o
- [1] Oxford BioDynamics plc. (11/2/20). "Press Release: Oxford BioDynamics Announces Strategic Partnership with Boca Biolistics in Order to Advance EpiSwitch Disease Severity Program for COVID-19". Oxford....
- [2] BiomX Inc.. (9/2/20). "Press Release: BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease". Ness Ziona....
- [3] Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA....
- [4] BiomX Ltd.. (12/12/18). "Press Release: BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD". Ness Ziona....
- [5] Protagen AG. (2/2/17). "Press Release: Protagen AG Join Forces with the U.S. National Cancer Institute to Answer Pressing Questions in Immuno-oncology"....
- [6] Protagen AG. (1/17/17). "Press Release: The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top